Article

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach

2024-02-01

Abstract excerpt

Uterine corpus endometrial carcinoma (UCEC) poses significant clinical challenges due to its high incidence and poor prognosis, exacerbated by the lack of effective screening methods. The standard treatment for UCEC typically involves surgical intervention, with radiation and chemotherapy as potential adjuvant therapies. In recent years, immunotherapy has emerged as a promising avenue for the advanced treatment of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ee7a8e85-2b05-52da-a21d-78c8add125d3
DOI: 10.3390/biomedinformatics4010019

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico ApproachDOI 10.3390/biomedinformatics4010019Read

Traditional and New Views on MSI-H/dMMR Endometrial Cancer.Semantic proximity Read

HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancersSemantic proximity Read

Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.Semantic proximity Read

Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical ProfilesSemantic proximity Read

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.Semantic proximity Read

CHD4 R975H mutant activates tumorigenic pathways and promotes stemness and M2-like macrophage polarization in endometrial cancer.Semantic proximity Read

Prognostic biomarker GOLM1 correlated with immune infiltrates in Endometrial cancerSemantic proximity Read

MCM10 : An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinomaSemantic proximity Read

MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentialsSemantic proximity Read

Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.Semantic proximity Read

Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labsSemantic proximity Read

Whole genome sequencing of endometrial cancer identifies novel subgroups, drivers, and actionable alterationsSemantic proximity Read